Table:
begin	end	state
1	11	non-cytoplasmic
12	31	transmembrane
32	58	cytoplasmic
59	83	transmembrane
84	88	non-cytoplasmic
89	109	transmembrane
110	137	cytoplasmic
138	157	transmembrane
158	174	non-cytoplasmic
175	194	transmembrane
195	202	cytoplasmic
203	223	transmembrane
224	229	non-cytoplasmic
230	255	transmembrane
256	292	cytoplasmic
293	315	transmembrane
316	338	non-cytoplasmic
339	361	transmembrane
362	376	cytoplasmic
377	393	transmembrane
394	398	non-cytoplasmic
399	425	transmembrane
426	481	cytoplasmic

Input:
>GFF5497 FitnessBrowser__WCS417:GFF5497
MLEVINDFLSGKVLIVLIVGLGGYFTIRSRFVQLRHFFHMFSVFKDSLKSSAGQLSSFQA
LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFIECSLGQLYKRTDAEG
TYRGGPAYYIQHGLQKRWLGMVMAFLLLVTFGFAFNGLQAHAVTHSLNNAFGLDTTYTGL
ALAVLLGLVFIGGIKRIASIADLLVPVKTLVYIAVTLYVIVLQFDHVPAMLATIVKSAFG
LDQAFGGLVGSAIIMGVKRGVFANEAGLGSAPNVAAVASVEHPIAQGVVQAFSVFLDTFV
ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSIMYNYY
LGESNLRFLVGNNRKVLMGYRALVLVLIFWGSIENLSTVFAFADITMTMLAFVNLFALAF
LFKIAMRILNDYDNQRAAGIKTPVFDSSQFPDLDLDRKAWPANPVKPEAATSAELNAQVQ
R

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server